What drugs does INTL MEDICATION SYS make?

INTL MEDICATION SYS has 10 FDA-approved drugs including CALCIUM CHLORIDE 10%.

What therapeutic areas does INTL MEDICATION SYS focus on?

INTL MEDICATION SYS focuses primarily on Cardiovascular and Metabolic.

Data updated: Mar 10, 2026

INTL MEDICATION SYS

CardiovascularMetabolic

Generics

INTL MEDICATION SYS is a generic drug manufacturer focused on Cardiovascular, Metabolic. Key products include EPINEPHRINE.

1982

Since

Drugs

Trials

100

Approved (2yr)

Key Drugs

CALCIUM CHLORIDE 10%

calcium chloride

· 2017

Recent Activity

ATROPINE SULFATE 2026-02-04

Labeling

SODIUM BICARBONATE 2026-01-13

LORAZEPAM 2026-01-05

Labeling

MORPHINE SULFATE 2025-12-22

Labeling

MORPHINE SULFATE 2025-12-22

Labeling

MORPHINE SULFATE 2025-12-22

Labeling

MORPHINE SULFATE 2025-12-22

Labeling

MORPHINE SULFATE 2025-12-22

Labeling

MORPHINE SULFATE 2025-12-22

Labeling

MORPHINE SULFATE 2025-12-22

Labeling

SEC Filings ProEarly access

Therapeutic Focus

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Cardiovascular 50%

1 drugs

Metabolic 50%

1 drugs

Pipeline Strength ProEarly access

Competitors ProEarly access

Merck big-pharma

Cardiovascular, Metabolic

Johnson & Johnson big-pharma

Cardiovascular, Metabolic

Bayer big-pharma

Cardiovascular, Metabolic

B BRAUN specialty

Metabolic, Cardiovascular

AstraZeneca big-pharma

Cardiovascular, Metabolic

INTL MEDICATION SYS

Key Drugs

Recent Activity

Therapeutic Focus

Pipeline Strength ProEarly access

Competitors ProEarly access

All Drugs (10)

Active (5)

Discontinued (5)

Company Info